Month: September 2022

BOSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced that management will be participating at the upcoming H.C. Wainwright’s 24th Annual Global Investment Conference taking place on September 12-14, 2022. Details for the event are as follows:H.C. Wainwright 24th Annual Global Investment ConferenceDate:   September 12-14, 2022Webcast:   Click HEREManagement will be available for virtual 1×1 meetings with investors. Please contact your H.C. Wainwright representative to request a meeting. A replay of the webcast presentation will be available in the Investor section of Galecto’s website at https://ir.galecto.com/news-and-events/events. About GalectoGalecto is a clinical...

TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) — Shawcor Ltd. (“Shawcor” or the “Company”) (TSX: SCL) announced that it has sold its Lake Superior Consulting (“LSC”) operating unit to a private investment group, including members of LSC management, in a transaction generating approximately C$8 million in gross proceeds. The LSC business, reported within the Company’s Pipeline and Pipe Services (“PPS”) segment, offers engineering, consulting and field inspection services to the US onshore pipeline and broader energy infrastructure markets. It generated revenue of approximately C$59 million with neutral adjusted EBITDA during the full year of 2021 and generated revenue of approximately C$26 million with an adjusted EBITDA loss of C$1 million during the first half of 2022. Proceeds from the sale will be used to reduce the Company’s existing...

MINNEAPOLIS, Sept. 06, 2022 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced that management will participate in the Morgan Stanley 20th Annual Global Healthcare Conference, which is being held at the Sheraton New York Times Square Hotel in New York, NY from September 12th-14th. Management will participate in a fireside chat on Tuesday, September 13th at 11:10 a.m. Eastern Time. A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company’s investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference. About Tactile...

MALVERN, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer and Co-Founder of Ocugen, will participate in an in-person fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022 in New York, NY. Details regarding Dr. Musunuri’s fireside chat are as follows:Event: H.C. Wainwright 24th Annual Global Investment ConferenceDate: September 12, 2022Time: 3:30 – 4:00 p.m. ETLocation: Lotte New York Palace HotelWebcast: Live Fireside ChatA live video webcast beginning at 3:30 p.m. ET on the day of the presentation will be available...

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform, announced today that Mai-Britt Zocca, the company’s President and CEO, will be participating in a fireside chat and investor meetings at the Morgan Stanley 20th Annual Global Healthcare Conference, taking place September 12 – 14, 2022. Fireside Chat DetailsDate and Time: Wednesday, September 14, 2022 at 8:35 a.m. ETPresenter: Mai-Britt Zocca, President & CEOWebcast Link: Here A webcast replay of the presentation will be available from the Investors section of the Company’s website at www.iobiotech.com for 180 days. About IO Biotech IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating...

WARMINSTER, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that the Company will participate in the following upcoming investor conferences taking place in New York: H.C. Wainwright 24th Annual Global Investment Conference (September 12-14, 2022)Company Presentation: Tuesday, September 13th at 12:30 pm ET Presenter: William Collier, President & Chief Executive OfficerBaird’s 2022 Global Healthcare Conference (September 13-14, 2022)Fireside Chat: Wednesday, September 14th at 10:15 am ET Presenters: William Collier, President & Chief Executive Officer; Dr. Gaston Picchio, Chief Development Officer; Michael McElhaugh,...

BOSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will participate in two upcoming investor conferences in New York, NY. Management will be participating in investor meetings at the H.C. Wainwright 24th Annual Global Investment Conference and at the Morgan Stanley 20th Annual Global Healthcare Conference, where Mark Manfredi, Ph.D., Chief Executive Officer of Ikena, will also be conducting a fireside chat. Details are as follows: H.C. Wainwright 24th Annual Global Investment ConferenceInvestor Meetings September 12-14, 2022 Morgan Stanley 20th Annual Global Healthcare ConferenceInvestor Meetings September 12-14, 2022Fireside Chat: Wednesday, September 14, 2022 at 11:45 a.m....